Skip to content

Interference Screw Mectascrew-B Postmarket Study

Cinical Outcomes of Mectascrew B Interference Screw

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06166784
Enrollment
27
Registered
2023-12-12
Start date
2023-10-19
Completion date
2026-01-31
Last updated
2023-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Cruciate Ligament Injuries Posterior Cruciate Ligament Tear

Brief summary

An observational prospective study with the aim to assess the clinical outcomes at 1year after surgery for a specific composite IS (Medacta Mectascrew B) in the reconstructive treatment of ruptured ACL or PCL by means of an autograft or allograft.

Detailed description

This is an observational prospective study with the aim toassess the clinical outcomes at 1year after surgery for a specific composite IS (Medacta Mectascrew B) at 12 months following ACL or PCL reconstruction. Patients with an ACL or PCL tear scheduled for surgery at OCM Klnik GmbH hospital will be enrolled in the study, after the subscription of informed consent. The injured ligament will be restored with an auto- or allograft that will be fixed with a composite IS (Mectascrew-B, Medacta International SA). Data concerning demography, preoperative clinical conditions, surgical details including device implanted, tendon harvesting procedure and complications occurred, postoperative clinical data (as per standard practice at 6 weeks, 6 and/or 12 months) will be prospectively collected, in order to assess the functional outcomes (IKDC objective and subjective) and the knee stability (ROM, Pivot Shift or Reverse Pivot Shift test, anterior or posterior drawer test) of the patients. The treated knee will be also evaluated radiologically by std x-ray according to standard practice to assess swelling, tunnel widening, and resorption problems. The results of this exam will be correlated to the pre-operative findings and to the functional and clinical outcomes evaluated with the different forms

Interventions

DEVICEMectascrew B

reconstruction of ACL or PCL rupture

Sponsors

Medacta International SA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Both genders * Patients older than 18 years * ACL or PCL damage requiring primary ACL or PCL reconstruction * Patient requiring ACL or PCL surgery with the use of Medacta MectaScrew B interference screw, according to Manufacturer IFU's, i.e. reconstructive therapy of ruptures to the anterior or posterior cruciate ligament by means of autologous grafts * Patients who are willing to participate in the study and have signed informed consent form.

Exclusion criteria

* Patients with contraindications according to IFU's * Patients with malignant diseases (at the time of surgery) * Patients with proven or suspected infections (at the time of surgery) * Patients with functional deficits on the affected extremity (at the time of surgery) * Patients with known incompatibility or allergy to products materials (at the time of surgery) * Concomitant ligament injury (grade ≥ 3)

Design outcomes

Primary

MeasureTime frameDescription
Functional outcomes evaluation12 monthsAssessment throught IKCD score. a patient-completed tool, which contains sections on knee symptoms (7 items), function (2 items), and sports activities (2 items). Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).

Secondary

MeasureTime frameDescription
Knee stability evaluation of ACL intervention6 weeks, 6 months, 12 monthsPivot shift test. A positive test indicate an injury at ACL
ACL integrity assessment6 weeks, 6 months, 12 monthsAnterior drawer test. An anterior translation more than 6 mm indicate a positive test with injuried ACL
Knee stability evaluation of PCL intervention6 weeks, 6 months, 12 monthsReverse Pivot Shift test. In the presence of a posterolateral injury with the knee flexed, the tibia follows gravity and drops into posterolateral subluxation (positive Reverse Pivot Shift Test).
Mobility outcomes evaluation6 weeks, 6 months, 12 monthsAssessment throught Range Of Motion of operated knee calculated as degree
Interference screw integration6 weeks, 6 months, 12 monthsEvaluation of ligament osteointegration, femoral/tibial tunnel widening, presence of fluid in the femoral/tibial tunnel by std x-ray
Incidence of adverse event6 weeks, 6 months, 12 monthscollection of adverse event
PCL integrity assessment6 weeks, 6 months, 12 monthsPosterior drawer test. The test is considered positive if there is a lack of end feel or excessive posterior translation

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026